DUAL GIP / GLP-1
Tirzepatide
Tirzepatide is a dual GIP / GLP-1 receptor agonist studied for substantial weight reduction and improved glycemic control. Weekly subcutaneous protocol.
VIAL SIZE
10 mg lyophilized
PURITY
>99% (HPLC, placeholder)
Buy more, get free vials.
Buy 1 get 1 free · Buy 4 get 2 free · Buy 6 get 3 free.
Add 3 more — unlock 2 free vials.
+1 FREE VIAL APPLIED
$69.69
PER VIAL
Research dosing
Typical research titration: 2.5 mg weekly, increasing by 2.5 mg every 4 weeks up to 15 mg. Placeholder.
Reconstitution
Reconstitute with 2 mL bacteriostatic water for a 5 mg/mL concentration.
Storage
Refrigerate at 2–8°C after reconstitution. Store lyophilized vial at –20°C.
Research context
FDA-approved for type 2 diabetes and obesity (Mounjaro/Zepbound). Used as research benchmark for dual agonists.
For laboratory research use only. Not for human consumption. Information shown is for research reference; dosing and storage details on this page are placeholders pending finalized internal documentation.